Search research articles
Contact Us
Filters
Showing results (1-10 of 45) with videos related to
Page
of 5
Sort By:
Cancer
|
May 4, 2001
Surrogate endpoint biomarkers and their modulation in cervical chemoprevention trials
M Follen, D Schottenfeld
Journal of the National Cancer Institute
|
March 4, 2000
Emerging technologies and cervical cancer
M Follen, R Richards-Kortum
Obstetrics and Gynecology Clinics of North America
|
June 1, 1996
Screening and chemoprevention of gynecologic tumors
D Schottenfeld, M Follen Mitchell, W K Hong
Gynecologic Oncology
|
September 18, 2007
A theory-aided dissemination strategy for emerging technologies in cervical cancer screening
E Shinn, K Basen-Engquist, B Crain, et al.
American Journal of Obstetrics and Gynecology
|
December 15, 1985
Cervical vascular malformation as a cause of antepartum and intrapartum bleeding in three diethylstilbestrol-exposed progeny
M M Follen, H E Fox, R U Levine
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
July 1, 1994
Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: the effects of tamoxifen
E G Silva, C S Tornos, M Follen-Mitchell
Journal of the National Cancer Institute
|
September 6, 2001
Why most randomized phase II cervical cancer chemoprevention trials are uninformative: lessons for the future
M Follen, F L Meyskens, E N Atkinson, et al.
Obstetrics and Gynecology
|
November 13, 2001
The management of ASCUS cervical cytologic abnormalities and HPV testing: a cautionary note
A L Herbst, K E Pickett, M Follen, et al.
Journal of Clinical Epidemiology
|
October 21, 1999
A comparison of C/B ratios from studies using receiver operating characteristic curve analysis
S B Cantor, C C Sun, G Tortolero-Luna, et al.
Optics Express
|
May 7, 2009
Low Temperature Fluorescence Imaging of Freeze-trapped Human Cervical Tissues
N Ramanujam, R Richards-Kortum, S Thomsen, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 45) with videos related to
Sort By:
Page
of 5
Cancer
|
May 4, 2001
Surrogate endpoint biomarkers and their modulation in cervical chemoprevention trials
M Follen, D Schottenfeld
Journal of the National Cancer Institute
|
March 4, 2000
Emerging technologies and cervical cancer
M Follen, R Richards-Kortum
Obstetrics and Gynecology Clinics of North America
|
June 1, 1996
Screening and chemoprevention of gynecologic tumors
D Schottenfeld, M Follen Mitchell, W K Hong
Gynecologic Oncology
|
September 18, 2007
A theory-aided dissemination strategy for emerging technologies in cervical cancer screening
E Shinn, K Basen-Engquist, B Crain, et al.
American Journal of Obstetrics and Gynecology
|
December 15, 1985
Cervical vascular malformation as a cause of antepartum and intrapartum bleeding in three diethylstilbestrol-exposed progeny
M M Follen, H E Fox, R U Levine
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
July 1, 1994
Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: the effects of tamoxifen
E G Silva, C S Tornos, M Follen-Mitchell
Journal of the National Cancer Institute
|
September 6, 2001
Why most randomized phase II cervical cancer chemoprevention trials are uninformative: lessons for the future
M Follen, F L Meyskens, E N Atkinson, et al.
Obstetrics and Gynecology
|
November 13, 2001
The management of ASCUS cervical cytologic abnormalities and HPV testing: a cautionary note
A L Herbst, K E Pickett, M Follen, et al.
Journal of Clinical Epidemiology
|
October 21, 1999
A comparison of C/B ratios from studies using receiver operating characteristic curve analysis
S B Cantor, C C Sun, G Tortolero-Luna, et al.
Optics Express
|
May 7, 2009
Low Temperature Fluorescence Imaging of Freeze-trapped Human Cervical Tissues
N Ramanujam, R Richards-Kortum, S Thomsen, et al.
Page
of 5